Satisfaction with treatment · endometrial hyperplasia
It is very uncertain whether LNG‐IUS changes satisfaction with treatment compared with non‐intrauterine progestogen (very low certainty).
1 finding from 1 review
Regression of EH ‐ Short · women with endometrial hyperplasia
LNG may leads to higher regression of EH ‐ Short compared with no treatment (low certainty).
1 finding from 1 review
Adverse effects associated with LNG‐IUS · women with endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hysterectomy rate · women with endometrial hyperplasia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · patients with endometriosis prior to standard IVF/ICSI
It is very uncertain whether long‐term GnRH agonist therapy changes live birth rate compared with no additional therapy (very low certainty).
1 finding from 1 review
Complication rate · patients with endometriosis prior to standard IVF/ICSI
It is very uncertain whether long‐term GnRH agonist therapy changes complication rate compared with no additional therapy (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · patients with endometriosis prior to standard IVF/ICSI
It is very uncertain whether long‐term GnRH agonist therapy changes clinical pregnancy rate compared with no additional therapy (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · patients with endometriosis prior to standard IVF/ICSI
It is very uncertain whether long‐term GnRH agonist therapy changes multiple pregnancy rate compared with no additional therapy (very low certainty).
1 finding from 1 review
Miscarriage · patients with endometriosis prior to standard IVF/ICSI
It is very uncertain whether long‐term GnRH agonist therapy changes miscarriage rate compared with no additional therapy (very low certainty).
1 finding from 1 review
Number of oocytes retrieved · patients with endometriosis prior to standard IVF/ICSI
1 finding from 1 review
Mean number of embryos · patients with endometriosis prior to standard IVF/ICSI
1 finding from 1 review
Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' · women with endometriosis
2 findings from 1 review
Self‐reported pain: menstrual pain reduction from baseline to end of treatment · women with endometriosis
1 finding from 1 review
Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' · women with endometriosis
2 findings from 1 review
Self‐reported pain (dysmenorrhoea) (dichotomous data) ‐ reduction of pain to zero at 6 months' · women with endometriosis
It is very uncertain whether combined oral contraceptive pill changes self‐reported pain (dysmenorrhoea) (dichotomous data): reduction of… compared with other medical treatment (very low certainty).
2 findings from 1 review
Regression rate at 6 months · women with atypical endometrial hyperplasia
It is very uncertain whether levonorgestrel‐releasing intrauterine system (LNG‐IUS) changes regression rate at 6 months compared with medroxyprogesterone (MPA) 10 mg (very low certainty).
1 finding from 1 review
Nausea · women with atypical endometrial hyperplasia
It is very uncertain whether levonorgestrel‐releasing intrauterine system (LNG‐IUS) changes nausea over 6‐month compared with medroxyprogesterone (MPA) 10 mg (very low certainty).
1 finding from 1 review
Vaginal bleeding over 6‐month · women with atypical endometrial hyperplasia
Levonorgestrel‐releasing intrauterine system (LNG‐IUS) may leads to higher vaginal bleeding over 6‐month compared with medroxyprogesterone (MPA) 10 mg (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · women with endometriosis
It is very uncertain whether NSAID changes pain relief compared with placebo (very low certainty).
1 finding from 1 review
Unintended effects from treatment · women with endometriosis
It is very uncertain whether NSAID changes unintended effects from treatment compared with placebo (very low certainty).
1 finding from 1 review